antiviral agents / administration & dosage*

Explore academic connections and research related to this keyword

235
Views
10
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Once-daily valacyclovir to reduce the risk of transmission of genital herpes
Corey L;Wald A;Patel R;Sacks SL;Tyring SK;Warren T;Douglas JM;Paavonen J;Morrow RA;Beutner KR;Stratc...
2004 The New England journal of medicine 474 views
2
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study
Hall CB;McBride JT;Walsh EE;Bell DM;Gala CL;Hildreth S;Ten Eyck LG;Hall WJ;;
1983 The New England journal of medicine 347 views
3
Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals
Schütz A;Moser S;Schwanke C;Schubert R;Luhn J;Gutic E;Lang T;Schleicher M;Haltmayer H;Gschwantler M;...
2018 journal of viral hepatitis 292 views
4
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Kwo PY;Poordad F;Asatryan A;Wang S;Wyles DL;Hassanein T;Felizarta F;Sulkowski MS;Gane E;Maliakkal B;...
2017 journal of hepatology 374 views
5
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
Wyles D;Poordad F;Wang S;Alric L;Felizarta F;Kwo PY;Maliakkal B;Agarwal K;Hassanein T;Weilert F;Lee...
2018 Hepatology (Baltimore, Md.) 285 views
6
A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C
Backus LI;Boothroyd DB;Phillips BR;Belperio P;Halloran J;Mole LA;;
2011 clinical gastroenterology and hepatology : the off... 261 views
7
Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies
Hezode C;Reau N;Svarovskaia ES;Doehle BP;Shanmugam R;Dvory-Sobol H;Hedskog C;McNally J;Osinusi A;Bra...
2018 journal of hepatology 297 views
8
Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques
Stittelaar KJ;Tisdale M;van Amerongen G;van Lavieren RF;Pistoor F;Simon J;Osterhaus AD;;
2008 Antiviral research 233 views
9
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen
Macdonald SJ;Watson KG;Cameron R;Chalmers DK;Demaine DA;Fenton RJ;Gower D;Hamblin JN;Hamilton S;Hart...
2004 Antimicrobial agents and chemotherapy 297 views
10
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
Lawitz E;Gane E;Pearlman B;Tam E;Ghesquiere W;Guyader D;Alric L;Bronowicki JP;Lester L;Sievert W;Gha...
2015 Lancet (London, England) 255 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't adult female male adolescent aged middle aged Drug Administration Schedule P.H.S.